Tang Carolyn C. 4
4 · Arcus Biosciences, Inc. · Filed Jan 27, 2025
Insider Transaction Report
Form 4
Tang Carolyn C.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2025-01-23+150,000→ 150,000 totalExercise: $13.33Exp: 2035-01-22→ Common Stock (150,000 underlying) - Award
Common Stock
2025-01-23+37,000→ 137,623 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.